
1. j parasitol res. 2013;2013:429736. doi: 10.1155/2013/429736. epub 2013 apr 3.

treatment plasmodium chabaudi parasites curcumin combination with
antimalarial drugs: drug interactions implications the
ubiquitin/proteasome system.

neto z(1), machado m, lindeza a, rosário v, gazarini ml, lopes d.

author information: 
(1)unidade de parasitologia, instituto de higiene e medicina tropical (ihmt),
universidade nova de lisboa, rua da junqueira 100, 1349-008 lisbon, portugal ;
centro de malária e doenças tropicais (cmdt), instituto de higiene e medicina
tropical (ihmt), universidade nova de lisboa, rua da junqueira 100, 1349-008
lisbon, portugal.

antimalarial drug resistance remains major obstacle malaria control.
evidence southeast asia shows resistance artemisinin combination
therapy (act) inevitable. ethnopharmacological studies confirmed the
efficacy curcumin plasmodium spp. drug interaction assays between
curcumin/piperine/chloroquine curcumin/piperine/artemisinin combinations 
the potential drug treatment interfere ubiquitin proteasome system
(ups) analyzed. vivo efficacy curcumin studied balb/c mice
infected plasmodium chabaudi clones resistant chloroquine and
artemisinin, drug interactions analyzed isobolograms. subtherapeutic 
doses curcumin, chloroquine, artemisinin administered mice, and
mrna collected following treatment rt-pcr analysis genes encoding
deubiquitylating enzymes (dubs). curcumin found nontoxic balb/c mice.
the combination curcumin/chloroquine/piperine reduced parasitemia 37% seven
days treatment versus control group's 65%, additive interaction 
was revealed. curcumin/piperine/artemisinin combination show favorable 
drug interaction murine model malaria. treatment mice with
subtherapeutic doses drugs resulted transient increase genes
encoding dubs indicating ups interference. curcumin join arsenal 
available antimalarial drugs, future studies exploring suitable drug partners
would interest.

doi: 10.1155/2013/429736 
pmcid: pmc3649349
pmid: 23691276 

